Stanley Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-24,800
Closed -$4.39M 42
2020
Q1
$4.39M Sell
24,800
-27,600
-53% -$5.2M 3.39% 13
2019
Q4
$10M Buy
52,400
+800
+2% +$144K 4.25% 7
2019
Q3
$8.68M Hold
51,600
4.25% 8
2019
Q2
$8.64M Buy
51,600
+8,000
+18% +$1.11M 4.16% 7
2019
Q1
$6.38M Hold
43,600
3.12% 17
2018
Q4
$5.83M Buy
43,600
+4,500
+12% +$738K 3.34% 14
2018
Q3
$7.45K Buy
39,100
+12,400
+46% +$2.28M 0.06% 13
2018
Q2
$4.45M Hold
26,700
1.96% 30
2018
Q1
$4.49M Buy
+26,700
New +$4.48M 2.03% 30

Other funds holding AGN

Stanley Capital Management's AGN Position: Q2 2020 in Review

Stanley Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 24,800 shares — an estimated $4.39M sold.

Stanley Capital Management first reported a position in AGN in Q1 2018 and held it in 9 quarters. The position peaked at $10M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Stanley Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Stanley Capital Management sold 24,800 Allergan plc shares in Q2 2020, an estimated $4.39M.
  • Stanley Capital Management first reported a position in Allergan plc in Q1 2018 and held it in 9 quarters.
  • Stanley Capital Management's Allergan plc position peaked at $10M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Stanley Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.